AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is...
30 insider purchases on record · latest filing 2025-08-18.
Insiders have also filed 15 sale transactions at ATAI.